Heron Neutron Medical - Public Comps and Valuation Multiples

Heron Neutron Medical Overview

About Heron Neutron Medical

Heron Neutron Medical Corp is engaged in the manufacturing, development and sales of medical equipment, etc. The Company currently focuses on the integration of talents to provide accelerator-based boron neutron capture therapy (AB-BNCT) total solutions, including proton accelerator system, neutron source target system, beam shaping assembly, treatment control system, treatment planning system, patients positioning system.

Founded

2017

HQ

Employees

Website

heron-neutron.com

Sectors

Medical Devices

Financials

LTM Revenue $0.3M

LTM EBITDA -$10.9M

EV

$2.0B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Heron Neutron Medical Financials

As of January 2026, Heron Neutron Medical reported last 12-month revenue of $0.3M and EBITDA of -$10.9M.

In the same period, Heron Neutron Medical achieved -$15.2M in LTM net income.

See Heron Neutron Medical valuation multiples based on analyst estimates

Heron Neutron Medical P&L

In the most recent fiscal year, Heron Neutron Medical reported EBITDA of -$7.6M.

Heron Neutron Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Heron Neutron Medical valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue	$0.3M	XXX	n/a	XXX	XXX	XXX
Gross Profit	n/a	XXX	-$0.1M	XXX	XXX	XXX
Gross Margin	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA	-$10.9M	XXX	-$7.6M	XXX	XXX	XXX
EBITDA Margin	-3895%	XXX	n/a	XXX	XXX	XXX
EBIT	-$15.5M	XXX	-$8.2M	XXX	XXX	XXX
EBIT Margin	-5528%	XXX	n/a	XXX	XXX	XXX
Net Profit	-$15.2M	XXX	-$8.2M	XXX	XXX	XXX
Net Margin	-5445%	XXX	n/a	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Heron Neutron Medical including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $0.3M. EBITDA for the last twelve months was -$10.9M.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2026)	Next Fiscal Year (2027)	Two Years Forward (2028)
Total Revenue	$0.3M	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	-$0.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	-$10.9M	Analyst estimates available to subscribers	-$7.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	-3895.0% EBITDA margin	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	-$15.5M	Analyst estimates available to subscribers	-$8.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	-5527.6% EBIT margin	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$15.2M	Analyst estimates available to subscribers	-$8.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-5444.8% net profit margin	Analyst estimates available to subscribers	n/a	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Heron Neutron Medical

This financial data table provides comprehensive performance metrics for Heron Neutron Medical, a company based in Taiwan. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Heron Neutron Medical generated $0.3M in revenue over the last twelve months.
The company achieved -$10.9M in EBITDA over the last twelve months.
Net income over the last twelve months reached -$15.2M.

Fiscal Year Performance

Fiscal year EBITDA was -$7.6M.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Heron Neutron Medical. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Heron Neutron Medical Stock Performance

Heron Neutron Medical has current market cap of TWD 74.6B (or $2.4B), and EV of TWD 63.3B (or $2.0B).

Market Cap Evolution

Heron Neutron Medical Stock Data

As of February 25, 2026, Heron Neutron Medical's stock price is TWD 474 (or $15).

See Heron Neutron Medical trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$2.0B	$2.4B	XXX	XXX	XXX	XXX	$-0.11

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Heron Neutron Medical Valuation Multiples

Heron Neutron Medical's trades at 7152.5x EV/Revenue multiple, and -183.6x EV/EBITDA.

See valuation multiples for Heron Neutron Medical and 15K+ public comps

Heron Neutron Medical Financial Valuation Multiples

As of February 25, 2026, Heron Neutron Medical has market cap of $2.4B and EV of $2.0B.

Equity research analysts estimate Heron Neutron Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Heron Neutron Medical has a P/E ratio of -154.9x.

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Market cap (current)	$2.4B	XXX	$2.4B	XXX	XXX	XXX
EV (current)	$2.0B	XXX	$2.0B	XXX	XXX	XXX
EV/Revenue	7152.5x	XXX	7152.5x	XXX	XXX	XXX
EV/EBITDA	-183.6x	XXX	-183.6x	XXX	XXX	XXX
EV/EBIT	-129.4x	XXX	-129.4x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	-154.9x	XXX	-154.9x	XXX	XXX	XXX
EV/FCF	-6.1x	XXX	-6.1x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Heron Neutron Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Heron Neutron Medical Margins & Growth Rates

Heron Neutron Medical's last 12 month revenue growth is 209%

Heron Neutron Medical's revenue per employee in the last FY averaged n/a, while opex per employee averaged $0.1M for the same period.

Heron Neutron Medical's rule of 40 is -46331% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Heron Neutron Medical's rule of X is -3372% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Heron Neutron Medical and other 15K+ public comps

Heron Neutron Medical Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue Growth	209%	XXX	1867%	XXX	XXX	XXX
EBITDA Margin	-3895%	XXX	-3895%	XXX	XXX	XXX
EBITDA Growth	31%	XXX	n/a	XXX	XXX	XXX
Rule of 40	-46331%	XXX	-3686%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	-3372%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	n/a	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial